Department of Urology, Eulji University School of Medicine, Seoul, Korea.
Int J Urol. 2013 Dec;20(12):1212-9. doi: 10.1111/iju.12150. Epub 2013 Apr 9.
Randomized controlled trials are one of the most reliable resources for assessing the effectiveness and safety of medical treatments. Low quality randomized controlled trials carry a large bias that can ultimately impair the reliability of their conclusions. The present study aimed to evaluate the quality of randomized controlled trials published in International Journal of Urology by using multiple quality assessment tools.
Randomized controlled trials articles published in International Journal of Urology were found using the PubMed MEDLINE database, and qualitative analysis was carried out with three distinct assessment tools: the Jadad scale, the van Tulder scale and the Cochrane Collaboration Risk of Bias Tool. The quality of randomized controlled trials was analyzed by publication year, type of subjects, intervention, presence of funding and whether an institutional review board reviewed the study.
A total of 68 randomized controlled trial articles were published among a total of 1399 original articles in International Journal of Urology. Among these randomized controlled trials, 10 (2.70%) were from 1994 to 1999, 23 (4.10%) were from 2000 to 2005 and 35 (4.00%) were from 2006 to 2011 (P = 0.494). On the assessment with the Jadad and van Tulder scale, the numbers and percentage of high quality randomized controlled trials increased over time. The studies that had institutional review board reviews, funding resources or that were carried out in multiple institutions had an increased percentage of high quality articles.
The numbers and percentage of high-quality randomized controlled trials published in International Journal of Urology have increased over time. Furthermore, randomized controlled trials with funding resources, institutional review board reviews or carried out in multiple institutions have been found to be of higher quality compared with others not presenting these features.
随机对照试验是评估医学治疗有效性和安全性最可靠的资源之一。低质量的随机对照试验存在较大的偏倚,最终可能会影响其结论的可靠性。本研究旨在使用多种质量评估工具评估《国际泌尿学杂志》发表的随机对照试验的质量。
使用 PubMed MEDLINE 数据库查找《国际泌尿学杂志》发表的随机对照试验文章,并使用三种不同的评估工具进行定性分析:Jadad 量表、van Tulder 量表和 Cochrane 协作风险偏倚工具。通过发表年份、研究对象类型、干预措施、资金来源以及机构审查委员会是否审查了研究来分析随机对照试验的质量。
在《国际泌尿学杂志》发表的总共 1399 篇原始文章中,有 68 篇随机对照试验文章。这些随机对照试验中,1994 年至 1999 年有 10 篇(2.70%),2000 年至 2005 年有 23 篇(4.10%),2006 年至 2011 年有 35 篇(4.00%)(P=0.494)。在使用 Jadad 和 van Tulder 量表进行评估时,高质量随机对照试验的数量和百分比随时间增加而增加。有机构审查委员会审查、资金来源或在多个机构进行的研究,高质量文章的比例更高。
《国际泌尿学杂志》发表的高质量随机对照试验的数量和百分比随时间增加而增加。此外,与没有这些特征的随机对照试验相比,有资金来源、机构审查委员会审查或在多个机构进行的随机对照试验质量更高。